Oxycodon/Naloxon Heumann

Oxycodone, the active ingredient in Oxycodon/Naloxon Heumann, is an opioid analgesic presented as a combination tablet for oral use. It treats moderate to severe pain in adult patients. Naloxone, the second active ingredient, is an opioid antagonist included to reduce misuse potential. GNH USA supplies Oxycodon/Naloxon Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxycodon/Naloxon Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxycodone/Naloxone is used for pain management within the opioid pathway, providing relief for several conditions: - Chronic non‑cancer pain: Improves pain control when combined with opioid therapy. - Cancer‑related pain: Enhances analgesia while reducing abuse risk. - Post‑operative surgical pain: Provides effective post‑operative analgesia. - Acute musculoskeletal pain: Offers short‑term pain relief after injury. - Severe pain episodes in palliative care: Delivers strong analgesia for end‑of‑life comfort.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Constipation: reduced bowel motility. - Drowsiness: sedation or fatigue. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation. - Headache: tension‑type or throbbing pain.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that may be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Opioid dependence: risk of physical dependence with prolonged use. - Hepatic impairment: liver function abnormalities. - Allergic reactions: rash, itching, or anaphylaxis. - Seizures: rare neurologic events.

When prescribing Oxycodone/Naloxone, clinicians should consider several safety measures: - Assess pain severity: confirm that opioid therapy is appropriate for the patient’s level of pain. - Review medical history: check for respiratory disorders, liver disease, or prior substance abuse. - Monitor for sedation: advise patients not to operate machinery or drive while sedated. - Adjust dose cautiously: titrate based on response and tolerability, especially in the elderly. - Educate on misuse risk: inform patients about the purpose of naloxone in the formulation. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Oxycodone/Naloxone interacts with several drug classes; careful management is required: Major Interactions (Avoid): - CNS depressants: concurrent use with benzodiazepines or barbiturates can cause profound respiratory depression. - MAO inhibitors: may precipitate severe hypertension or serotonin syndrome. - CYP3A4 inhibitors: strong inhibitors (e.g., ketoconazole) increase oxy‑opioid levels, raising overdose risk. Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors: drugs like fluoxetine can reduce oxycodone metabolism, altering analgesic effect. - Diuretics: may enhance hypotensive effects when combined with opioid‑induced vasodilation. - Anticholinergics: can worsen constipation, a common opioid side effect.